30/06/2020 Unable to reach any conclusion with an emphasis of matters /Others 2020 Reviewed Consolidated Q2 30/06/2020 Unable to reach any conclusion with an emphasis of matters /Others 2020
30/06/2020 Unable to reach any conclusion with an emphasis of matters /Others 2020 Reviewed Consolidated Q2 30/06/2020 Unable to reach any conclusion with an emphasis of matters /Others 2020
Consolidated Year 31/12/2020 2020 Company Q2 30/06/2020 2020 Consolidated Q2 30/06/2020 2019 Reviewed Company Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters
-2 / 18-3 Application for Establishing Representative Office Abroad Securities Company / Derivatives Intermediary Name of Company
Application for Establishing Representative Office Abroad Securities Company / Derivatives Intermediary Name of Company
2020 Reviewed Company Q2 30/06/2020 Unable to reach any conclusion with an emphasis of matters /Others 2020 Reviewed Consolidated Q2 30/06/2020 Unable to reach any conclusion with an emphasis of
Reviewed Company Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters 2019 Reviewed Consolidated Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters 2019 Reviewed
Statement MD&A Financial Statement Revise 2020 Reviewed Company Q2 30/06/2020 Unable to reach any conclusion with an emphasis of matters /Others 2020 Reviewed Consolidated Q2 30/06/2020 Unable to reach
Statement MD&A Financial Statement Revise 2020 Reviewed Company Q3 30/09/2020 2020 Reviewed Consolidated Q3 30/09/2020 2020 Reviewed Company Q2 30/06/2020 Unable to reach any conclusion with an
Statement MD&A Financial Statement Revise 2020 Reviewed Company Q3 30/09/2020 2020 Reviewed Consolidated Q3 30/09/2020 2020 Reviewed Company Q2 30/06/2020 Unable to reach any conclusion with an